Author
S. Lilla
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2017-2024 · peak 6/yrCo-Author Collaboration Network
10 top collaborators · 39 mutual co-author links20 papers
Recent·Most cited
The helminth TGF-beta mimic TGM4 is a modular ligand that binds CD44, CD49d and TGF-beta receptors to preferentially target myeloid cells
S. Singh, D. J. Smyth, K. Cunningham, A. Mukundan, C.-H. Byron, C. S. Hinck, M. P. J. White, C. Ciancia, N. Wosowska, A. Sanders, R. Jin, S. Lilla, S. Zanivan, C. Schoenherr, G. Inman, , R. M. Maizels
This paper identifies TGM4, a helminth TGF-beta mimic, as a modular ligand that selectively targets myeloid cells through specific receptor interactions, differing from TGM1's broader T cell targeting.
bioRxiv · Nov 13, 2023 · PreprintImmunology
Engineered immunomodulatory extracellular vesicles derived from epithelial cells acquire capacity for positive and negative T cell co-stimulation in cancer and autoimmunity
F. Kugeratski, V. LeBleu, D. Dowlatshahi, H. Sugimoto, K. Arian, Y. Fan, L. Huang, D. Wills, S. Lilla, K. Hodge, S. Zanivan, K. McAndrews, R. Kalluri
This study engineers extracellular vesicles from epithelial cells to express immunomodulatory proteins, showing they can induce both positive and negative T cell co-stimulation in cancer and autoimmunity.
bioRxiv · Nov 2, 2023 · PreprintCancer Biology
Mitochondrial outer membrane integrity regulates a ubiquitin-dependent NF-κB inflammatory response
E. Vringer, J. Riley, A. Black, C. Cloix, S. Lilla, H. Walczak, M. Gyrd-Hansen, D. Huang, S. Zanivan, S. Tait
This study shows that mitochondrial outer membrane permeabilization triggers ubiquitin-dependent NF-κB inflammation by recruiting NEMO to ubiquitylated mitochondria.
bioRxiv · Sep 21, 2023 · PreprintCell Biology
The eIF4A2 negative regulator of mRNA translation promotes extracellular matrix deposition to accelerate hepatocellular carcinoma initiation
M. Moore, L. Pardo, L. Mitchell, T. Schmidt, J. Waldron, S. May, M. Mueller, R. Smith, D. Strathdee, S. Bryson, K. Hodge, S. Lilla, A. Wilczynska, L. McGarry, S. Gillen, , J. C. Norman
The paper shows that eIF4A2, a negative regulator of mRNA translation, promotes ECM deposition to accelerate HCC initiation by influencing integrin-mediated signaling and senescence exit.
bioRxiv · Aug 16, 2023 · PreprintCancer Biology
Tumour mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade
M. Mahmood, E. M. Liu, A. L. Shergold, E. Tolla, J. Tait-Mulder, A. H. Uribe, E. Shokry, A. L. Young, S. Lilla, M. Kim, T. Park, J. L. Manchon, C. Rodriguez-Antona, R. C. Walters, R. J. Springett, , P. A. Gammage
This study shows that mitochondrial DNA mutations in complex I genes drive aerobic glycolysis, enhancing immune checkpoint blockade response in tumors.
bioRxiv · Mar 21, 2023 · PreprintCancer Biology
Cancer-associated fibroblasts produce matrix-bound vesicles that influence endothelial cell function
A. Santi, E. J. Kay, L. J. Neilson, L. McGarry, S. Lilla, M. Mullin, N. R. Paul, F. Fercoq, G. Koulouras, G. Rodriguez-Blanco, D. Athineos, S. Mason, M. Hughes, Y. Kieffer, C. Nixon, , S. Zanivan
CAFs with a myofibroblastic-like phenotype transfer proteins to ECs, including plasma membrane receptors, through matrix-bound EVs.
bioRxiv · Jan 13, 2023 · PreprintCancer Biology
PTEN deficiency exposes a requirement for an ARF GTPase module in integrin-dependent invasion in ovarian cancer.
K. Nikolatou, E. Sandilands, A. Roman-Fernandez, E. M. Cumming, E. C. Freckmann, S. Lilla, L. Buetow, L. McGarry, M. Neilson, R. Shaw, D. Strachan, C. Miller, D. T. Huang, I. A. McNeish, J. C. Norman, , D. Bryant
This study identifies ARF6 as a critical vulnerability in PTEN-deficient ovarian cancer, showing its role in integrin-dependent invasion and its inverse association with patient outcomes.
bioRxiv · Nov 29, 2022Cancer Biology
Spatial regulation of the glycocalyx component Podocalyxin is a switch for pro-metastatic function
A. Roman-Fernandez, M. Mansour, F. G. Kugeratski, J. Anand, E. Sandilands, L. Galbraith, K. Rakovic, E. C. Freckmann, E. M. Cumming, J. Park, K. Nikolatou, S. Lilla, R. Shaw, D. Strachan, S. Mason, , D. M. Bryant
This study identifies PODXL as a decoy receptor for GAL3, revealing its role in promoting metastasis through integrin-based invasion and differential cortical targeting regulated by ubiquitination.
bioRxiv · Nov 4, 2022 · PreprintCell Biology
A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation
P. Altea-Manzano, G. Doglioni, A. M. Cuadros, E. Nolan, J. Fernandez-Garcia, Q. Wu, F. Cidre-Aranaz, A. Montagne, M. Planque, O. Marin-Bejar, J. Van Elsen, I. Vermeire, D. Broekaert, C. Riera-Domingo, F. Richard, , S.-M. Fendt
This study identifies palmitate-rich metastatic niches as promoters of metastasis by enhancing p65 acetylation and NF-κB signaling in breast cancer cells.
bioRxiv · Oct 24, 2022Cancer Biology
MICAL1 activation by PAK1 mediates actin filament disassembly
D. J. McGarry, G. Castino, S. Lilla, S. Zanivan, M. F. Olson
This study identifies PAK1-mediated phosphorylation of MICAL1 as a mechanism for actin filament disassembly, linking extracellular signals to cytoskeleton regulation through RHO GTPase signaling.
bioRxiv · Sep 15, 2021 · PreprintCell Biology
Maturation, developmental site, and pathology dictate murine neutrophil function
J. B. G. Mackey, A. J. McFarlane, T. Jamieson, R. Jackstadt, X. L. Raffo-Iraolagoitia, J. Secklehner, X. Cortes-Lavaud, F. Fercoq, W. Clarke, A. Hedley, K. Gilroy, S. Lilla, J. Vuononvirta, G. J. Graham, K. De Filippo, , L. M. Carlin
This study identifies Ly6G expression levels as a marker for neutrophil maturation stages and shows spleen-derived neutrophils mature faster with distinct transcriptional profiles.
bioRxiv · Jul 21, 2021 · PreprintImmunology
THEM6-mediated lipid remodelling sustains stress resistance in cancer
A. Blomme, C. Peter, E. Mui, G. Rodriguez Blanco, L. M. Mason, L. E. Jamieson, G. H. McGregor, S. Lilla, C. Ntala, R. Patel, M. Thiry, S. H. Kung, C. A. Ford, L. K. Rushworth, D. J. McGarry, , H. Y. Leung
This study identifies THEM6 as a marker of ADT resistance in prostate cancer, showing its role in lipid homeostasis and stress response, and highlights it as a potential therapeutic target.
bioRxiv · Apr 4, 2021Cancer Biology
Spatial enrichment of phosphoinositide metabolism is a molecular switch to promote metastasis.
M. Nacke, E. Sandilands, K. Nikolatou, A. Roman-Fernandez, S. Mason, R. Patel, S. Lilla, T. Yelland, L. Galbraith, L. McGarry, J. P. Morton, E. Shanks, H. Y. Leung, S. Zanivan, S. Ismail, , D. Bryant
This study identifies IQSEC1 variants that spatially regulate phosphoinositide metabolism to switch cell behavior from growth to invasion, with implications for metastasis.
bioRxiv · Sep 22, 2020 · PreprintCancer Biology
Schlafen family member 5 (SLFN5) regulates LAT1-mediated mTOR activation in castration-resistant prostate cancer
R. S. Martinez, M. J. Salji, L. Rushworth, C. Ntala, G. Rodriguez Blanco, A. Hedley, W. Clark, P. Peixoto, E. Hervouet, E. Renaude, S. H. Kung, L. C. Galbraith, C. Nixon, S. Lilla, G. M. MacKay, , H. Y. Leung
This study identifies SLFN5 as an AR-regulated biomarker in CRPC that promotes tumour growth by regulating LAT1-mediated mTOR activation.
bioRxiv · Sep 17, 2020 · PreprintCancer Biology
PYCR1-dependent proline synthesis in cancer-associated fibroblasts is required for the deposition of pro-tumorigenic extracellular matrix
E. J. Kay, K. Paterson, C. Riero Domingo, D. Sumpton, H. Daebritz, S. Tardito, C. Boldrini, J. R. Hernandez-Fernaud, D. Athineos, S. Dhayade, E. Stepanova, E. Gjerga, L. J. Neilson, S. Lilla, A. Hedley, , S. Zanivan
This study identifies PYCR1-dependent proline synthesis in cancer-associated fibroblasts as critical for collagen production and tumor progression, suggesting PYCR1 as a therapeutic target to inhibit pro-tumorigenic extracellular matrix deposition.
bioRxiv · May 30, 2020 · PreprintCancer Biology
The Mammalian Cytosolic Thioredoxin Reductase Pathway Acts via a Membrane Protein to Reduce ER-localised Proteins
X. Cao, S. Lilla, Z. Cao, M. A. Pringle, O. B. Oka, P. J. Robinson, T. Szmaja, M. van Lith, S. Zanivan, N. Bulleid
The paper demonstrates that the cytosolic thioredoxin reductase pathway reduces ER-localized proteins via a membrane protein, essential for ER redox homeostasis and protein folding.
bioRxiv · Nov 4, 2019Cell Biology
Formate induces a metabolic switch in nucleotide and energy metabolism
K. Oizel, J. Tait-Mulder, J. Fernandez-de-Cossio-Diaz, M. Pietzke, H. Brunton, S. Dhayade, D. Athineos, S. Lilla, G. Rodriguez Blanco, D. Sumpton, G. M. Mackay, K. Blyth, S. Zanivan, J. Meiser, A. Vazquez
This study shows formate induces a metabolic switch increasing adenine nucleotides, glycolysis, and repressing AMPK, with implications for cancer metabolism.
bioRxiv · Aug 16, 2019Biochemistry
Cell-substrate adhesion drives Scar/WAVE activation and phosphorylation, which controls pseudopod lifetime
S. Singh, P. Thomason, S. Lilla, M. Schacks, Q. Tang, B. Goode, L. Machesky, K. Rottner, R. H. Insall
The paper shows that cell-substrate adhesion drives Scar/WAVE phosphorylation, which limits pseudopod lifetime, independent of chemotactic signals.
bioRxiv · Aug 12, 2019 · PreprintCell Biology
CYRI (FAM49) proteins are local inhibitors of Scar/WAVE induced lamellipodia that bind directly to active Rac1
L. Fort, J. Batista, P. A. Thomason, H. J. Spence, J. Greaves, K. J. Martin, K. I. Anderson, P. Brown, S. Lilla, M. P. Neilson, P. Tafelmeyer, S. Zanivan, S. Ismail, N. C. O. Tomkinson, L. H. Chamberlain, , L. M. Machesky
This study identifies CYRI proteins as local inhibitors of Scar/WAVE-induced lamellipodia that bind to active Rac1, regulating protrusion size and complexity.
bioRxiv · Nov 29, 2017Cell Biology